Previous close | 0.0246 |
Open | 0.0246 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0246 - 0.0246 |
52-week range | 0.0010 - 0.0250 |
Volume | |
Avg. volume | 19 |
Market cap | 615,541 |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings date | 29 Apr 2024 - 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Leonovus Inc. (TSXV: LTV) (the "Company" or "Leonovus") announces that it has signed a non-binding Letter of Intent ("LOI") to sell substantially all its software and patent assets to Cylentium Research Ltd. ("CRL"), a Delaware corporation, for $2,500,000 in an all-cash transaction (the "Transaction").